The University of Chicago Header Logo

Connection

Bernard Roizman to Animals

This is a "connection" page, showing publications Bernard Roizman has written about Animals.
Connection Strength

1.380
  1. The Story behind the Science: On the discovery of respiratory syncytial virus. mBio. 2025 Mar 12; 16(3):e0307424.
    View in: PubMed
    Score: 0.056
  2. The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments. Proc Natl Acad Sci U S A. 2017 05 09; 114(19):E3823-E3829.
    View in: PubMed
    Score: 0.033
  3. PML plays both inimical and beneficial roles in HSV-1 replication. Proc Natl Acad Sci U S A. 2016 May 24; 113(21):E3022-8.
    View in: PubMed
    Score: 0.031
  4. Role of activating transcription factor 3 in the synthesis of latency-associated transcript and maintenance of herpes simplex virus 1 in latent state in ganglia. Proc Natl Acad Sci U S A. 2015 Sep 29; 112(39):E5420-6.
    View in: PubMed
    Score: 0.029
  5. Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation. Proc Natl Acad Sci U S A. 2015 Jan 06; 112(1):E49-55.
    View in: PubMed
    Score: 0.028
  6. Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs. Proc Natl Acad Sci U S A. 2014 Nov 18; 111(46):E4991-6.
    View in: PubMed
    Score: 0.028
  7. The stability of herpes simplex virus 1 ICP0 early after infection is defined by the RING finger and the UL13 protein kinase. J Virol. 2014 May; 88(10):5437-43.
    View in: PubMed
    Score: 0.026
  8. HSV-1 degrades, stabilizes, requires, or is stung by STING depending on ICP0, the US3 protein kinase, and cell derivation. Proc Natl Acad Sci U S A. 2014 Feb 04; 111(5):E611-7.
    View in: PubMed
    Score: 0.026
  9. Selective degradation of mRNAs by the HSV host shutoff RNase is regulated by the UL47 tegument protein. Proc Natl Acad Sci U S A. 2013 Apr 30; 110(18):E1669-75.
    View in: PubMed
    Score: 0.025
  10. The herpes simplex virus host shutoff RNase degrades cellular and viral mRNAs made before infection but not viral mRNA made after infection. J Virol. 2013 Apr; 87(8):4516-22.
    View in: PubMed
    Score: 0.025
  11. HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed. Proc Natl Acad Sci U S A. 2013 Feb 05; 110(6):E498-506.
    View in: PubMed
    Score: 0.025
  12. The virion host shutoff RNase plays a key role in blocking the activation of protein kinase R in cells infected with herpes simplex virus 1. J Virol. 2013 Mar; 87(6):3271-6.
    View in: PubMed
    Score: 0.024
  13. An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol. 2013; 67:355-74.
    View in: PubMed
    Score: 0.024
  14. Overexpression of the ubiquitin-specific protease 7 resulting from transfection or mutations in the ICP0 binding site accelerates rather than depresses herpes simplex virus 1 gene expression. J Virol. 2012 Dec; 86(23):12871-8.
    View in: PubMed
    Score: 0.024
  15. Induction of apoptosis accelerates reactivation of latent HSV-1 in ganglionic organ cultures and replication in cell cultures. Proc Natl Acad Sci U S A. 2012 Sep 04; 109(36):14616-21.
    View in: PubMed
    Score: 0.024
  16. HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46):18820-4.
    View in: PubMed
    Score: 0.023
  17. Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. J Neurovirol. 2011 Dec; 17(6):512-7.
    View in: PubMed
    Score: 0.023
  18. The checkpoints of viral gene expression in productive and latent infection: the role of the HDAC/CoREST/LSD1/REST repressor complex. J Virol. 2011 Aug; 85(15):7474-82.
    View in: PubMed
    Score: 0.022
  19. Circadian CLOCK histone acetyl transferase localizes at ND10 nuclear bodies and enables herpes simplex virus gene expression. Proc Natl Acad Sci U S A. 2010 Oct 12; 107(41):17721-6.
    View in: PubMed
    Score: 0.021
  20. Interwoven roles of cyclin D3 and cdk4 recruited by ICP0 and ICP4 in the expression of herpes simplex virus genes. J Virol. 2010 Oct; 84(19):9709-17.
    View in: PubMed
    Score: 0.021
  21. Role of herpes simplex virus ICP27 in the degradation of mRNA by virion host shutoff RNase. J Virol. 2010 Oct; 84(19):10182-90.
    View in: PubMed
    Score: 0.021
  22. The novel HSV-1 US5-1 RNA is transcribed off a domain encoding US5, US4, US3, US2 and alpha22. Virol J. 2010 May 21; 7:103.
    View in: PubMed
    Score: 0.020
  23. Role of herpes simplex virus ICP0 in the transactivation of genes introduced by infection or transfection: a reappraisal. J Virol. 2010 May; 84(9):4222-8.
    View in: PubMed
    Score: 0.020
  24. ICP0 enables and monitors the function of D cyclins in herpes simplex virus 1 infected cells. Proc Natl Acad Sci U S A. 2009 Aug 25; 106(34):14576-80.
    View in: PubMed
    Score: 0.019
  25. Nuclear retention of ICP0 in cells exposed to HDAC inhibitor or transfected with DNA before infection with herpes simplex virus 1. Proc Natl Acad Sci U S A. 2008 Dec 23; 105(51):20488-93.
    View in: PubMed
    Score: 0.018
  26. The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem. J Virol. 2009 Jan; 83(1):181-7.
    View in: PubMed
    Score: 0.018
  27. The interaction of herpes simplex virus 1 regulatory protein ICP22 with the cdc25C phosphatase is enabled in vitro by viral protein kinases US3 and UL13. J Virol. 2008 May; 82(9):4533-43.
    View in: PubMed
    Score: 0.017
  28. Role of cellular phosphatase cdc25C in herpes simplex virus 1 replication. J Virol. 2008 May; 82(9):4527-32.
    View in: PubMed
    Score: 0.017
  29. Proteolytic cleavage of VP1-2 is required for release of herpes simplex virus 1 DNA into the nucleus. J Virol. 2008 Apr; 82(7):3311-9.
    View in: PubMed
    Score: 0.017
  30. Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex. Proc Natl Acad Sci U S A. 2007 Oct 23; 104(43):17134-9.
    View in: PubMed
    Score: 0.017
  31. In transduced cells, the US3 protein kinase of herpes simplex virus 1 precludes activation and induction of apoptosis by transfected procaspase 3. J Virol. 2007 Oct; 81(19):10242-8.
    View in: PubMed
    Score: 0.017
  32. Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow. Proc Natl Acad Sci U S A. 2007 Jul 24; 104(30):12474-8.
    View in: PubMed
    Score: 0.017
  33. Separation of receptor-binding and profusogenic domains of glycoprotein D of herpes simplex virus 1 into distinct interacting proteins. Proc Natl Acad Sci U S A. 2007 Mar 06; 104(10):4142-6.
    View in: PubMed
    Score: 0.016
  34. Mapping of key functions of the herpes simplex virus 1 U(S)3 protein kinase: the U(S)3 protein can form functional heteromultimeric structures derived from overlapping truncated polypeptides. J Virol. 2007 Feb; 81(4):1980-9.
    View in: PubMed
    Score: 0.016
  35. The egress of herpesviruses from cells: the unanswered questions. J Virol. 2006 Jul; 80(13):6716-7; author replies 6717-9.
    View in: PubMed
    Score: 0.016
  36. ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc Natl Acad Sci U S A. 2006 Jun 27; 103(26):9993-8.
    View in: PubMed
    Score: 0.016
  37. State and role of SRC family kinases in replication of herpes simplex virus 1. J Virol. 2006 Apr; 80(7):3349-59.
    View in: PubMed
    Score: 0.015
  38. U(S)3 and U(S)3.5 protein kinases of herpes simplex virus 1 differ with respect to their functions in blocking apoptosis and in virion maturation and egress. J Virol. 2006 Apr; 80(8):3752-64.
    View in: PubMed
    Score: 0.015
  39. Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptor. Proc Natl Acad Sci U S A. 2006 Apr 04; 103(14):5508-13.
    View in: PubMed
    Score: 0.015
  40. Herpes simplex virus 1 ICP22 regulates the accumulation of a shorter mRNA and of a truncated US3 protein kinase that exhibits altered functions. J Virol. 2005 Jul; 79(13):8470-9.
    View in: PubMed
    Score: 0.015
  41. Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells. J Virol. 2005 May; 79(9):5272-7.
    View in: PubMed
    Score: 0.014
  42. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces. Proc Natl Acad Sci U S A. 2005 Apr 19; 102(16):5838-43.
    View in: PubMed
    Score: 0.014
  43. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004 Dec; 14(6):453-71.
    View in: PubMed
    Score: 0.014
  44. Cells lacking NF-kappaB or in which NF-kappaB is not activated vary with respect to ability to sustain herpes simplex virus 1 replication and are not susceptible to apoptosis induced by a replication-incompetent mutant virus. J Virol. 2004 Nov; 78(21):11615-21.
    View in: PubMed
    Score: 0.014
  45. Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc Natl Acad Sci U S A. 2004 Jun 22; 101(25):9411-6.
    View in: PubMed
    Score: 0.014
  46. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol. 2004 Apr; 78(8):4185-96.
    View in: PubMed
    Score: 0.013
  47. Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol. 2004 Mar; 78(5):2169-78.
    View in: PubMed
    Score: 0.013
  48. Herpes simplex virus 1 gene expression is accelerated by inhibitors of histone deacetylases in rabbit skin cells infected with a mutant carrying a cDNA copy of the infected-cell protein no. 0. J Virol. 2003 Dec; 77(23):12671-8.
    View in: PubMed
    Score: 0.013
  49. Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity. J Virol. 2003 Dec; 77(24):13194-202.
    View in: PubMed
    Score: 0.013
  50. Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12408-13.
    View in: PubMed
    Score: 0.013
  51. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc Natl Acad Sci U S A. 2003 Jul 22; 100(15):8963-8.
    View in: PubMed
    Score: 0.013
  52. The herpes simplex virus 1 US3 protein kinase blocks caspase-dependent double cleavage and activation of the proapoptotic protein BAD. J Virol. 2003 Jun; 77(11):6567-73.
    View in: PubMed
    Score: 0.013
  53. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol. 2003 Jun; 77(12):7101-5.
    View in: PubMed
    Score: 0.013
  54. The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1. J Virol. 2003 Mar; 77(6):3759-67.
    View in: PubMed
    Score: 0.012
  55. Truncated forms of glycoprotein D of herpes simplex virus 1 capable of blocking apoptosis and of low-efficiency entry into cells form a heterodimer dependent on the presence of a cysteine located in the shared transmembrane domains. J Virol. 2002 Nov; 76(22):11469-75.
    View in: PubMed
    Score: 0.012
  56. An early regulatory function required in a cell type-dependent manner is expressed by the genomic but not the cDNA copy of the herpes simplex virus 1 gene encoding infected cell protein 0. J Virol. 2002 Oct; 76(19):9744-55.
    View in: PubMed
    Score: 0.012
  57. Herpes simplex viruses: is a vaccine tenable? J Clin Invest. 2002 Jul; 110(2):145-51.
    View in: PubMed
    Score: 0.012
  58. Characterization of the novel E3 ubiquitin ligase encoded in exon 3 of herpes simplex virus-1-infected cell protein 0. Proc Natl Acad Sci U S A. 2002 Jun 11; 99(12):7889-94.
    View in: PubMed
    Score: 0.012
  59. Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection. Proc Natl Acad Sci U S A. 2002 Jun 11; 99(12):8318-23.
    View in: PubMed
    Score: 0.012
  60. Cation-independent mannose 6-phosphate receptor blocks apoptosis induced by herpes simplex virus 1 mutants lacking glycoprotein D and is likely the target of antiapoptotic activity of the glycoprotein. J Virol. 2002 Jun; 76(12):6197-204.
    View in: PubMed
    Score: 0.012
  61. Second-site mutation outside of the U(S)10-12 domain of Deltagamma(1)34.5 herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase R and partially restores neurovirulence. J Virol. 2002 Feb; 76(3):942-9.
    View in: PubMed
    Score: 0.011
  62. U(S)3 protein kinase of herpes simplex virus 1 blocks caspase 3 activation induced by the products of U(S)1.5 and U(L)13 genes and modulates expression of transduced U(S)1.5 open reading frame in a cell type-specific manner. J Virol. 2002 Jan; 76(2):743-54.
    View in: PubMed
    Score: 0.011
  63. RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J Virol. 2001 Sep; 75(17):8105-16.
    View in: PubMed
    Score: 0.011
  64. The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc Natl Acad Sci U S A. 2001 Aug 28; 98(18):10410-5.
    View in: PubMed
    Score: 0.011
  65. The domains of glycoprotein D required to block apoptosis depend on whether glycoprotein D is present in the virions carrying herpes simplex virus 1 genome lacking the gene encoding the glycoprotein. J Virol. 2001 Jul; 75(13):6166-72.
    View in: PubMed
    Score: 0.011
  66. Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. Proc Natl Acad Sci U S A. 2001 Feb 13; 98(4):1877-82.
    View in: PubMed
    Score: 0.011
  67. Posttranslational processing of infected cell protein 22 mediated by viral protein kinases is sensitive to amino acid substitutions at distant sites and can be cell-type specific. J Virol. 2000 Dec; 74(23):11210-4.
    View in: PubMed
    Score: 0.011
  68. Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J Virol. 2000 Dec; 74(24):11782-91.
    View in: PubMed
    Score: 0.011
  69. Herpes simplex virus 1 open reading frames O and P are not necessary for establishment of latent infection in mice. J Virol. 2000 Oct; 74(19):9019-27.
    View in: PubMed
    Score: 0.010
  70. The essential protein encoded by the UL31 gene of herpes simplex virus 1 depends for its stability on the presence of UL34 protein. Proc Natl Acad Sci U S A. 2000 Sep 26; 97(20):11002-7.
    View in: PubMed
    Score: 0.010
  71. hnRNPA2B1 Associated with Recruitment of RNA into Exosomes Plays a Key Role in Herpes Simplex Virus 1 Release from Infected Cells. J Virol. 2020 06 16; 94(13).
    View in: PubMed
    Score: 0.010
  72. The herpes simplex virus 1 U(L)34 protein interacts with a cytoplasmic dynein intermediate chain and targets nuclear membrane. J Virol. 2000 Feb; 74(3):1355-63.
    View in: PubMed
    Score: 0.010
  73. Identification of a novel expressed open reading frame situated between genes U(L)20 and U(L)21 of the herpes simplex virus 1 genome. Virology. 2000 Jan 20; 266(2):275-85.
    View in: PubMed
    Score: 0.010
  74. Small dense nuclear bodies are the site of localization of herpes simplex virus 1 U(L)3 and U(L)4 proteins and of ICP22 only when the latter protein is present. J Virol. 2000 Jan; 74(1):523-8.
    View in: PubMed
    Score: 0.010
  75. Replication-competent herpes simplex viral vectors for cancer therapy. Adv Virus Res. 2000; 55:409-24.
    View in: PubMed
    Score: 0.010
  76. GADD45? Activated Early in the Course of Herpes Simplex Virus 1 Infection Suppresses the Activation of a Network of Innate Immunity Genes. J Virol. 2019 04 01; 93(7).
    View in: PubMed
    Score: 0.009
  77. RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. Proc Natl Acad Sci U S A. 2014 Jan 28; 111(4):E484-91.
    View in: PubMed
    Score: 0.007
  78. Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1. Gene Ther. 2011 Nov; 18(11):1098-102.
    View in: PubMed
    Score: 0.005
  79. Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int J Radiat Biol. 2009 May; 85(5):421-31.
    View in: PubMed
    Score: 0.005
  80. The order Herpesvirales. Arch Virol. 2009; 154(1):171-7.
    View in: PubMed
    Score: 0.005
  81. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A. 2008 Nov 25; 105(47):18490-5.
    View in: PubMed
    Score: 0.005
  82. Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res. 2007 Oct 01; 67(19):9214-20.
    View in: PubMed
    Score: 0.004
  83. Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity. Cancer Res. 2007 Sep 01; 67(17):8301-6.
    View in: PubMed
    Score: 0.004
  84. ReVOLT: radiation-enhanced viral oncolytic therapy. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):637-46.
    View in: PubMed
    Score: 0.004
  85. Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1. J Virol. 2006 Feb; 80(3):1110-20.
    View in: PubMed
    Score: 0.004
  86. Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses. Cancer Res. 2005 Oct 15; 65(20):9479-84.
    View in: PubMed
    Score: 0.004
  87. Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model. Neuro Oncol. 2005 Jul; 7(3):213-24.
    View in: PubMed
    Score: 0.004
  88. Modulation of vascular remodeling induced by a brief intraluminal exposure to the recombinant R7020 strain of Herpes simplex-1. J Vasc Surg. 2005 Jan; 41(1):115-21.
    View in: PubMed
    Score: 0.004
  89. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A. 2004 Feb 10; 101(6):1714-9.
    View in: PubMed
    Score: 0.003
  90. Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus. J Vasc Surg. 2003 Jun; 37(6):1294-300.
    View in: PubMed
    Score: 0.003
  91. The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma. Gene Ther. 2002 Jan; 9(1):75-80.
    View in: PubMed
    Score: 0.003
  92. Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo. Gene Ther. 2001 Dec; 8(24):1840-6.
    View in: PubMed
    Score: 0.003
  93. Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts. Proc Natl Acad Sci U S A. 2001 Oct 23; 98(22):12665-70.
    View in: PubMed
    Score: 0.003
  94. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis. Gene Ther. 2001 May; 8(10):769-77.
    View in: PubMed
    Score: 0.003
  95. Genetically engineered HSV in the treatment of glioma: a review. Rev Med Virol. 2000 Jan-Feb; 10(1):17-30.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.